-
What’s the story with Fosamax?
Recent reports have women wondering if they should stop taking this widely prescribed osteoporosis drug. In 1995, the FDA approved alendronate (Fosamax) for the treatment of postmenopausal osteoporosis, a bone-weakening condition that affects more than eight million women and causes 1.5 million fractures each year in the United States. Fosamax increases bone mineral density and […]
